FDA Approved: LORBRENA — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved Lorlatinib (LORBRENA) as the original application for treatment of ALK-positive metastatic non-small cell lung cancer in adults who progressed on o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Lorbrena (lorlatinib)

Snippet

ORIG AP for LORBRENA (LORLATINIB)